Health - Mental Health latest news

Public attitudes in England towards people with mental health problems remain broadly sympathetic, according to a new survey by the Department of Health. The public is generally understanding of people with mental health problems, with 85% thinking they deserve our sympathy and more than 8 out of 10 saying society needs to be more tolerant towards them.

Mental health charity Rethink has branded findings released by the Department of Health on attitudes towards people with mental health problems as "shocking, ignorant, and unacceptable in today's society.

Commenting on the release of the Department of Health's 2008 survey into public attitudes towards mental ill health, Mind's Chief Executive Paul Farmer said: "Overall, the general picture is that attitudes towards mental health are at best static - it's the reason why some of the leading mental health charities got together to form

Today's mother often juggles full-time employment, household chores and parenting, but a growing number of women are taking on yet another responsibility-caring for an aging loved one. Next week, as Americans observe both Mother's Day and mental health Month, mental health america encourages mothers to take the Mental Health Connection Challenge by building their social support networks to help cope with the stress of their demanding lives.

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults and met all safety and efficacy endpoints. "Adults with ADHD often find it challenging to focus and organize during the day.

People with shorter arms and legs may be at a higher risk for developing dementia later in life compared to people with longer arms and legs.

Forest Laboratories's study results show Lexapro significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder.

Shire plc announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).

Eli Lilly and Company announced that FDA has approved Strattera for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.